Alex participated in NINDS forum nonprofits to discuss ways to motivate the next generation of researchers

Alex participated in NINDS forum nonprofits to discuss ways to motivate the next generation of researchers

Alex was talking at the 13th NINDS nonprofit forum “Progress through Partnership” Panelist Dr. Alex Shcheglovitov, an assistant professor in the department of neurobiology and anatomy at the University of Utah, discusses ways to motivate the next generation of researchers. PHOTO: MARLEEN VAN DEN NESTE (from https://nihrecord.nih.gov) ...
Read More
A new postdoc at our lab – Dr. Simone Chiola

A new postdoc at our lab – Dr. Simone Chiola

Simone is from Italy and received his PhD in Functional and Structural Genomics at SISSA (Trieste). Prior to the PhD, he graduated in Medical Biotechnology at the University of Turin. At the lab, his project will be focused on SHANK3 gene haploinsufficiency and Autism Spectrum Disorders (ASDs). Mutations found in patients mostly cause a loss of function of SHANK3 and are associated to epilepsy and ASD. ...
Read More
Postdoc is wanted

Postdoc is wanted

We are looking for a postdoc interested in studying human stem cell-derived neurons and organoids from patients with different developmental disorders. A postdoctoral position is available in the Shcheglovitov Lab at the University of Utah to study the biochemical and functional properties of human neurons and organoids derived from patient-specific and CRISPR/Cas9-engineered induced pluripotent stem cells for modeling autism, intellectual disability, and epilepsy. We particularly invite applications from ambitious, exquisite, and motivated individuals with substantial neuroscience-related experience in molecular biology, biochemistry, physiology, or imaging. The work in our lab is currently centered around two NIH-funded research projects: Project 1: Cellular and molecular mechanisms disrupted in 22q13 deletion syndrome and autism. We previously demonstrated that SHANK3-deficient human cortical neurons derived from induced pluripotent stem cells (iPSCs) acquired from 22q13 deletion syndrome patients with autism and intellectual disability have severely impaired excitatory synaptic transmission (Shcheglovitov et al., Nature 2013). However, the cellular and molecular mechanisms responsible for the development of these deficits remain unknown. The main...
Read More